Your browser doesn't support javascript.
loading
Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer.
Miyoshi, Tomohiro; Ito, Hiroyuki; Wakabayashi, Masashi; Hashimoto, Tadayoshi; Sekino, Yuta; Suzuki, Kenji; Tsuboi, Masahiro; Moriya, Yasumitsu; Yoshino, Ichiro; Isaka, Tetsuya; Hattori, Aritoshi; Mimae, Takahiro; Isaka, Mitsuhiro; Maniwa, Tomohiro; Endo, Makoto; Yoshioka, Hiroshige; Nakagawa, Kazuo; Nakajima, Ryu; Tsutani, Yasuhiro; Saji, Hisashi; Okada, Morihito; Aokage, Keiju; Fukuda, Haruhiko; Watanabe, Shun-Ichi.
Affiliation
  • Miyoshi T; Division of Thoracic Surgery, Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Ito H; Department of Thoracic Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Wakabayashi M; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Hashimoto T; Translational Research Support Section, National Cancer Center Hospital East, Chiba, Japan.
  • Sekino Y; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Suzuki K; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
  • Tsuboi M; Division of Thoracic Surgery, Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Moriya Y; Department of Thoracic Surgery, Chiba Rosai Hospital, Chiba, Japan.
  • Yoshino I; Department of Thoracic Surgery, International University of Health and Welfare School of Medicine, Chiba, Japan.
  • Isaka T; Department of Thoracic Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Hattori A; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
  • Mimae T; Department of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Isaka M; Department of Thoracic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Maniwa T; Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Endo M; Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Yoshioka H; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan.
  • Nakagawa K; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Nakajima R; Department of General Thoracic Surgery, Osaka City General Hospital, Osaka, Japan.
  • Tsutani Y; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.
  • Saji H; Department of Chest Surgery, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Okada M; Department of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Aokage K; Division of Thoracic Surgery, Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Fukuda H; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Watanabe SI; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Eur J Cardiothorac Surg ; 64(6)2023 Dec 01.
Article in En | MEDLINE | ID: mdl-37930048
OBJECTIVES: This study aimed to identify the risk factors for pulmonary functional deterioration after wedge resection for early-stage lung cancer with ground-glass opacity, which remain unclear, particularly in low-risk patients. METHODS: We analysed 237 patients who underwent wedge resection for peripheral early-stage lung cancer in JCOG0804/WJOG4507L, a phase III, single-arm confirmatory trial. The changes in forced expiratory volume in 1 s were calculated pre- and postoperatively, and a cutoff value of -10%, the previously reported reduction rate after lobectomy, was used to divide the patients into 2 groups: the severely reduced group (≤-10%) and normal group (>-10%). These groups were compared to identify predictors for severe reduction. RESULTS: Thirty-seven (16%) patients experienced severe reduction. Lesions with a total tumour size ≥1 cm were significantly more frequent in the severely reduced group than in the normal group (89.2% vs 71.5%; P = 0.024). A total tumour size of ≥1 cm [odds ratio (OR), 3.287; 95% confidence interval (CI), 1.114-9.699: P = 0.031] and pleural indentation (OR, 2.474; 95% CI, 1.039-5.890: P = 0.041) were significant predictive factors in the univariable analysis. In the multivariable analysis, pleural indentation (OR, 2.667; 95% CI, 1.082-6.574; P = 0.033) was an independent predictive factor, whereas smoking status and total tumour size were marginally significant. CONCLUSIONS: Of the low-risk patients who underwent pulmonary wedge resection for early-stage lung cancer, 16% experienced severe reduction in pulmonary function. Pleural indentation may be a risk factor for severely reduced pulmonary function in pulmonary wedge resection.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Neoplasms Limits: Humans Language: En Journal: Eur J Cardiothorac Surg Journal subject: CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Neoplasms Limits: Humans Language: En Journal: Eur J Cardiothorac Surg Journal subject: CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: